(Q43828630)

27 November 2017

title

Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation (English)

1 reference

27 November 2017

0 references

cytomegaloviral disease

1 reference

Jung C

1

1 reference

27 November 2017

Engelmann E

series ordinal

2

1 reference

27 November 2017

Borner K

series ordinal

3

1 reference

27 November 2017

Offermann G

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Transplantation Proceedings

27 November 2017

published in

1 reference

27 November 2017

volume

33

1 reference

27 November 2017

issue

7-8

1 reference

27 November 2017

page(s)

3621-3623

1 reference

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Prophylaxis of cytomegalovirus infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Ganciclovir pharmacokinetics during renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902558-1

7 January 2021

10.1016/S0041-1345(01)02558-1

Identifiers

DOI

1 reference

27 November 2017

1 reference